###begin article-title 0
Neuregulin3 alters cell fate in the epidermis and mammary gland
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 290 294 <span type="species:ncbi:10090">mice</span>
###xml 533 538 <span type="species:ncbi:10090">mouse</span>
###xml 630 635 <span type="species:ncbi:10090">mouse</span>
The Neuregulin family of ligands and their receptors, the Erbb tyrosine kinases, have important roles in epidermal and mammary gland development as well as during carcinogenesis. Previously, we demonstrated that Neuregulin3 (Nrg3) is a specification signal for mammary placode formation in mice. Nrg3 is a growth factor, which binds and activates Erbb4, a receptor tyrosine kinase that regulates cell proliferation and differentiation. To understand the role of Neuregulin3 in epidermal morphogenesis, we have developed a transgenic mouse model that expresses Nrg3 throughout the basal layer (progenitor/stem cell compartment) of mouse epidermis and the outer root sheath of developing hair follicles.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
Transgenic females formed supernumerary nipples and mammary glands along and adjacent to the mammary line providing strong evidence that Nrg3 has a role in the initiation of mammary placodes along the body axis. In addition, alterations in morphogenesis and differentiation of other epidermal appendages were observed, including the hair follicles. The transgenic epidermis is hyperplastic with excessive sebaceous differentiation and shows striking similarities to mouse models in which c-Myc is activated in the basal layer including decreased expression levels of the adhesion receptors, alpha6-integrin and beta1-integrin.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
These results indicate that the epidermis is sensitive to Nrg3 signaling, and that this growth factor can regulate cell fate of pluripotent epidermal cell populations including that of the mammary gland. Nrg3 appears to act, in part, by inducing c-Myc, altering the proliferation and adhesion properties of the basal epidermis, and may promote exit from the stem cell compartment. The results we describe provide significant insight into how growth factors, such as Nrg3, regulate epidermal homeostasis by influencing the balance between stem cell renewal, lineage selection and differentiation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 662 671 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg1&#945;</italic>
###xml 683 684 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 699 711 695 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amphiregulin</italic>
###xml 754 767 750 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amphiregulin </italic>
###xml 800 801 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 878 909 874 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Amphiregulin, Egf, and Tgf&#945;</italic>
###xml 1076 1077 1068 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1111 1117 1103 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb1 </italic>
###xml 1121 1126 1113 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb2</italic>
###xml 1237 1238 1229 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1239 1241 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1503 1505 1495 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1506 1508 1498 1500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 677 681 <span type="species:ncbi:10090">mice</span>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
###xml 1132 1137 <span type="species:ncbi:10090">mouse</span>
###xml 1244 1249 <span type="species:ncbi:10090">Mouse</span>
###xml 1517 1522 <span type="species:ncbi:10090">mouse</span>
Neuregulins are a family of ligands that signal through the four Erbb receptor tyrosine kinases to activate pathways. This network mediates a wide range of processes that have relevance to both developmental processes and cancer, including cell adhesion, differentiation, proliferation, migration and death [1]. Our previous studies suggested that Nrg3 signaling acts to promote the initiation of mammary placode development [2]. The cognate receptor for Nrg3, Erbb4, is required for terminal differentiation of the mammary gland and lactation fails in its absence [3,4]. Impaired mammary epithelial proliferation and lobuloalveolar defects are also observed in Nrg1alpha-null mice [5]. Analysis of Amphiregulin-null mice demonstrated the requirement of Amphiregulin for ductal outgrowth at puberty [6]. Studies of compound null mutations for genes for the Egf-related ligands (Amphiregulin, Egf, and Tgfalpha) demonstrated failed lactation due to abnormal alveolar development and differentiation, whereas no lactation defect is apparent when these genes are singly mutated [6]. Studies of mammary tissue from Erbb1 and Erbb2-null mouse models have shown that these genes have important roles in mammary ductal outgrowth/morphogenesis [7-10]. Mouse models which overexpress the ligand, Nrg1, or the Erbb2 receptor (both wild-type and activated forms) display severe hyperplastic epidermal and/or mammary phenotypes depending on the cell type specificity of promoter used to drive transgene expression [11-15]. These mouse models have provided a useful framework for understanding how this ligand/receptor network acts to promote differentiation, outgrowth, and carcinogenesis of epithelial tissues.
###end p 9
###begin p 10
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 296 307 296 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr/Erbb1 </italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 489 497 489 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Waved-2 </italic>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Egfr </italic>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 754 756 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 873 875 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 971 973 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1086 1088 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1089 1091 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1280 1282 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 262 266 <span type="species:ncbi:10090">Mice</span>
###xml 469 473 <span type="species:ncbi:10090">Mice</span>
Egf and Egf-like ligands that signal through Egfr were initially discovered and named due to their profound effects on epidermal development [16-18]. Egf increases epidermal thickness and cellularity and stimulates proliferation of epidermal keratinocytes [16]. Mice with targeted disruptions of Egfr/Erbb1 are usually embryonically lethal but this is strain-dependent, so it is possible to analyze hypomorphs, and viable strains display epithelial hypoplasia [19-21]. Mice harbouring the Waved-2 allele of Egfr develop abnormal hair that appears wavy and also display a mild lactation defect [22]. Other Egf-like ligands expressed by keratinocytes include Amphiregulin [23], Betacellulin [24], Heparin-binding Egf-like growth factor [25], and TGFalpha [26]. Using wound healing models, Nrg1/Heregulin (HRG) has been implicated in epithelial migration and differentiation [27]. The Nrg1 isoforms, HRGalpha and HRGbeta, elicit different effects in cultured keratinocytes [28]; HRGalpha acts as a potent motility factor whereas HRGbeta has no effect on migration in wound healing assays [27,28]. In contrast, in normal melanocytes, HRGbeta significantly enhances cell migration, but not proliferation, while HRGalpha has no effect on migration or cell growth of normal melanocytes [29]. Despite the profound biological effects that Egf-like ligands elicit, their modes of action are not yet fully understood, particularly with respect to their ability to regulate cell fate and lineage commitment.
###end p 10
###begin p 11
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ska </italic>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3</italic>
###xml 731 733 731 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 991 993 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 994 996 994 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 997 999 997 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1197 1202 1197 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1787 1792 1787 1792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 279 284 <span type="species:ncbi:10090">mouse</span>
###xml 423 427 <span type="species:ncbi:10090">Mice</span>
###xml 1137 1142 <span type="species:ncbi:10090">mouse</span>
Mammary placodes are thought to arise as a result of local cell migration [30] and early stages are characterized by epithelial stratification [31,32]. Our previous studies indicated that Nrg3 promotes the differentiation of squamous epithelia into mammary epithelia [2]. In the mouse embryo, Nrg3 appears to regulate epithelial stratification or local epithelial aggregations at the sites that mammary placodes will form. Mice harbouring the ska mutation, a hypomorphic allele of Nrg3, often fail to form placode three; this can be restored after culture with recombinant Nrg3-Egf. Placode morphogenesis is governed by molecules that alter cell adhesion dynamics and, in some cases, proliferation of pluripotent epithelial cells [33,34]. In the mammary gland, as with the development of all epidermal appendages, undifferentiated stem cells are committed to specific lineages and a population of cells with a high capacity for proliferation is delimited, which subsequently differentiates [33,35,36]. The role of Nrg3 signaling in the determination of epidermal stem cell fate remains largely uncharacterized. Therefore, we developed a mouse model to examine the outcome of ectopic expression of Nrg3 in the basal layer of the developing epithelia under the control of the Keratin14 (K14) promoter. This promoter results in expression beyond the normal spatial and temporal domains of Nrg3 expression into the stem cell compartment. Expression of Nrg3 in the basal layer of the epidermis resulted in alterations in a variety of epidermal organs including the skin, hair follicles, sebaceous glands, external genitalia and mammary glands. Analysis of epithelial differentiation and progenitor markers suggests that differentiation of progenitor cell populations is profoundly altered by Nrg3 expression.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Nrg3 is expressed in the developing epidermis and hair follicles
###end title 13
###begin p 14
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 136 141 <span type="species:ncbi:10090">mouse</span>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
We have shown previously, using both in situ hybridization and immunohistochemistry, that Nrg3 is expressed in the developing embryonic mouse epidermis from E12-E13 [2]. Nrg3 is also expressed in developing hair follicles at E14.5 (Fig. 1A). To investigate Nrg3 expression in postnatal skin, we used immunohistochemistry on both frozen and fixed mouse epidermis (Fig. 1B and data not shown). We found that Nrg3 is expressed in the granular and cornified layers and in very few cells of the basal layer of the postnatal interfollicular epidermis, and at low to moderate levels in the hair follicles along the outer root sheath including the bulge and along the inner root sheath (Fig. 1B and Additional File 1).
###end p 14
###begin p 15
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3</italic>
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Endogenous expression pattern of <italic>Nrg3</italic>, K14-<italic>Nrg3 </italic>transgene, and postnatal phenotype of a K14-<italic>Nrg3 </italic>founder mouse</bold>
###xml 113 114 113 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 259 264 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 468 469 467 468 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 734 735 732 733 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 778 782 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3</italic>
###xml 892 893 887 888 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 916 921 911 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 809 814 <span type="species:ncbi:9606">human</span>
###xml 831 837 <span type="species:ncbi:9986">rabbit</span>
###xml 864 868 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
Endogenous expression pattern of Nrg3, K14-Nrg3 transgene, and postnatal phenotype of a K14-Nrg3 founder mouse. (A) Nrg3 is expressed in the developing hair follicles at E14.5. Inset shows frozen section of the whole mount which confirmed the localization of Nrg3 in the nascent hair follicles (brackets). Arrowheads indicate intense basal epithelial expression. Suprabasal and diffuse mesenchymal Nrg3 expression are also observed. The scale bar represents 100 mum. (B) Nrg3 is expressed in the granular and cornified layers and in a few basal cells (arrows) of the postnatal epidermis and at low to moderate levels in the hair follicles in the outer root sheath and inner root sheath at P7. The scale bar represents 50 mum in (B). (C) Transgene used for ectopic expression of Nrg3. The transgene includes a human K14 promoter, a rabbit beta-globin intron and an SV40 polyadenylation site. (D) Phenotype of one K14-Nrg3 founder at P7. Mutant mice are hairless and have thick, pale and wrinkled skin. A non-transgenic littermate is on the left. b, bulge; irs, inner root sheath; ors, outer root sheath; sg, sebaceous gland.
###end p 15
###begin title 16
Ectopic expression of Nrg3 in the epidermis causes epidermal defects and early lethality
###end title 16
###begin p 17
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 219 224 219 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 751 756 751 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 180 195 <span type="species:ncbi:10090">transgenic mice</span>
###xml 233 238 <span type="species:ncbi:9606">human</span>
###xml 405 410 <span type="species:ncbi:10090">mouse</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 1215 1219 <span type="species:ncbi:10090">mice</span>
To extend the temporal and spatial range of Nrg3 expression in the epidermis, and determine whether Nrg3 can modulate the development of epidermis and its appendages, we generated transgenic mice expressing full-length Nrg3 from the human K14 promoter (Fig. 1C). The K14 promoter is expressed in the periderm starting at E9.5 and, once stratified, in the basal layer (progenitor/stem cell compartment) of mouse epidermis and the outer root sheath of the hair follicles [37]. Founder mice were produced by pronuclear injection of the linearized transgene into fertilized eggs (Additional File 2). Levels of transgene expression in the epidermis of mice were determined by immunohistochemistry or by in situ hybridization (data not shown). Six male K14-Nrg3 transgenic founders exhibited a similar thickened, wrinkled, hairless phenotype that encompassed the entire skin of the animal (Fig. 1D). Of these, four died a few days after birth or were unwell and were culled. However, two male founders expressing lower transgene levels were viable and exhibited hyperplastic epithelial phenotypes but did not display other epidermal appendage phenotypes, or the phenotypes were less severe. Furthermore, two male founder mice that were mosaic for transgene levels expressed variable levels of transgene expression and were also viable.
###end p 17
###begin title 18
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Histopathology of K14-Nrg3 transgenic skin
###end title 18
###begin p 19
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 256 261 256 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 1034 1039 1034 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1213 1218 1213 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C, D</xref>
###xml 991 995 <span type="species:ncbi:10090">mice</span>
Histological examination of seven independent K14-Nrg3 transgenic founders revealed that the skin shared several unusual features. The epidermis displayed expanded suprabasal, granular and cornified layers when compared to non-transgenic littermates (Fig. 2A, B). Nucleated cells were present throughout the epidermis, even in the later differentiated compartments, except for the cornified layers, which were anucleate. An increase in the cellular density of the dermis was also observed. A large infiltration of fibroblasts was apparent and the fat layer appeared much thinner in the transgenic skin. Hair follicles were hyperplastic and mis-orientated within the dermis and sebaceous glands were mis-positioned and hyperplastic. All components of the hair follicle are present and differentiation proceeds normally but is disrupted at a very late stage so that the hair fiber either fails to form or when a fiber does form it does not penetrate through the thickened epithelium. However, mice derived from one lower expressing K14-Nrg3 transgenic line did form some sparse wavy hair but only one hair type (zigzag) was present compared to the four hair types normally found in non-transgenic littermates (Fig. 2C, D).
###end p 19
###begin p 20
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">K14-<italic>Nrg3 </italic>transgenic mice display hyperplastic epithelia and hair follicleab normalities</bold>
###xml 135 140 135 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 184 185 184 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 256 257 256 257 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 687 688 687 688 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 756 757 756 757 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 815 820 815 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 835 840 835 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 894 895 894 895 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 944 949 944 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
K14-Nrg3 transgenic mice display hyperplastic epithelia and hair follicleab normalities. Histological analysis of dorsal skin from K14-Nrg3 and age-matched non-transgenic littermate. (A) Skin section stained with H&E from non-transgenic littermate at P7. (B) Skin section stained with H&E from K14-Nrg3 transgenic founder at P7. The transgenic epidermis shows hyperplasia and enlargement of cells and nuclei compared with non-transgenic littermates. Expanded suprabasal, granular and cornified layers are present in the interfollicular epidermis (IFE). A large infiltration of fibroblasts was observed in the transgenic skin. Hair follicles and sebaceous glands were also hyperplastic. (C) Four hair shaft types are present in a non-transgenic littermate.(D) Only one hair shaft type (zigzag) is present in a lower Nrg3 expressing K14-Nrg3 transgenic line that did form some sparse wavy hair. (E) Transgenic expression pattern of Nrg3 from K14-Nrg3 transgenic skin at P7. Nrg3 is expressed in the basal, suprabasal, and granular layers of the epithelium and in the outer root sheath (ORS) of hair follicles.(G, guard; Au, Auchene; Aw, Awl; Z, zigzag) The scale bar represents 50 mum.
###end p 20
###begin p 21
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 374 379 374 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 441 446 441 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
Using an antibody to the Egf domain of Nrg3, we detected Nrg3 expression in the basal, suprabasal, and granular layers of the epithelium and in the outer root sheath of hair follicles in the transgenic founder lines (Fig. 2E). Cytoplasmic and membrane staining is observed suggesting that both membrane-spanning and secreted forms of Nrg3 are produced in the transgenic K14-Nrg3 mice, as expected from the isoform of Nrg3 present in the K14-Nrg3 construct. Non-transgenic littermates express Nrg3 in a few basal and in the granular and cornified layers and low to moderate levels throughout the hair follicles (Fig. 1B).
###end p 21
###begin title 22
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Altered Erbb receptor activation is observed in K14-Nrg3 transgenic skin
###end title 22
###begin p 23
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 245 251 245 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A&#8211;D</xref>
###xml 872 877 872 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E, F</xref>
###xml 1057 1059 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G</xref>
###xml 1080 1081 1080 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1100 1105 1100 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3H</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
###xml 146 151 <span type="species:ncbi:10090">mouse</span>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 898 903 <span type="species:ncbi:10090">mouse</span>
Erbb1, Erbb2, and Erbb3 expression has been reported in both human and mouse skin [15,38,39]. Erbb4 expression has not been reported in postnatal mouse epidermis although expression has been observed in both embryonic and adult human skin [38]. Erbb4 is expressed in the epithelia of the developing mammary placode from the time it is morphologically distinct [2]. We examined expression of the four Erbb receptors in both transgenic and non-transgenic postnatal skin. Erbb1 and Erbb2 are expressed in the basal epithelia and differentiating epidermal layers and in the outer root sheath of the hair follicles of both non-transgenic and transgenic skin (Fig. 3A-D). Erbb3 is expressed in the basal, suprabasal layers and at higher levels in the granular epithelial layers and in the outer root sheath of the hair follicles of both transgenic and non-transgenic skin (Fig. 3E, F). In non-transgenic mouse epidermis, we detect only very low levels of Erbb4 in the interfollicular epidermis and we observed low levels of expression in the hair follicles (Fig. 3G and Additional File 1). However, in K14-Nrg3 transgenic skin, we observed significantly increased levels of Erbb4 in the epidermis (mainly cytosolic and weak membranous) (Fig. 3H), which suggest that Nrg3 expression in the basal epithelia might induce an autocrine signaling loop.
###end p 23
###begin p 24
###xml 92 97 92 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 0 125 0 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression and activation of Erbb receptors in dorsal epidermis from non-transgenic and K14-<italic>Nrg3 </italic>transgenic littermates at P7</bold>
###xml 128 129 128 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 131 132 131 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 134 135 134 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 137 138 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 178 179 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 181 182 181 182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 184 185 184 185 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 187 188 187 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 230 232 230 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 236 237 236 237 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 309 311 309 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 395 397 395 397 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E </bold>
###xml 401 402 401 402 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 526 528 526 528 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G </bold>
###xml 532 533 532 533 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 703 708 703 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 939 940 938 939 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1100 1105 1099 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1452 1453 1451 1452 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 1455 1461 1454 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 1498 1515 1497 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JM and CYT Erbb4 </italic>
###xml 1626 1632 1625 1631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYT-1 </italic>
###xml 1636 1642 1635 1641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYT-2 </italic>
###xml 1675 1680 1674 1679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1729 1734 1728 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JM-a </italic>
###xml 1738 1743 1737 1742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JM-b </italic>
###xml 1833 1838 1832 1837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 2042 2048 2041 2047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
Expression and activation of Erbb receptors in dorsal epidermis from non-transgenic and K14-Nrg3 transgenic littermates at P7. (A, C, E, G) Skin from non-transgenic littermate. (B, D, F, H) Skin from K14-Nrg3 transgenic founder. (A and B) Erbb1 is expressed on the cell membranes throughout the IFE and ORS. (C and D) Erbb2 is weakly expressed on the cell membranes throughout the IFE and ORS. (E and F) Erbb3 is expressed on the cell membranes throughout the IFE and ORS and is more highly expressed in the granular layers. (G and H) Erbb4 is expressed at very low levels in the IFE and at low levels in the hair follicles of a non-transgenic littermate. Erbb4 is expressed at increased levels in K14- Nrg3 transgenic skin throughout the differentiating layers of the IFE and in the ORS (mainly cytosolic and weak membranous). Basal expression of receptor in the IFE and ORS is denoted by arrows in A-H. The scale bar represents 50 mum. (I) Immunoprecipitation and immunoblot analysis of tyrosine phosphorylation of Erbb1, Erbb2, Erbb3, or Erbb4 immunoprecipitates from dorsal non-transgenic or K14-Nrg3 transgenic skin. Each of the four Erbbs was immunoprecipitated (IP) from 1 mg of lysate and analyzed by immunoblotting (IB) with anti-phosphotyrosine (P-Tyr). The filters were stripped and reprobed with receptor-specific antibodies to determine receptor levels. W denotes wild-type non-transgenic skin sample and T denotes transgenic skin sample.(J) Erbb4 isoforms expressed in the epidermis. JM and CYT Erbb4 isoform levels as determined by semi-quantitative RT-PCR. Dorsal skin displays similar levels of expression of CYT-1 and CYT-2 levels in non-transgenic and K14-Nrg3 transgenic epidermis. Differential expression of JM-a and JM-b levels were observed such that one of the isoforms is preferentially expressed in the K14-Nrg3 transgenic epidermis (T) compared with that isolated from non-transgenic littermates (W). Three independent transgenic lines (T16, T25, T52) were analyzed and compared with three non-transgenic siblings. Gapdh was amplified in parallel as a control.
###end p 24
###begin p 25
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I</xref>
We explored the signaling events that mediate the Nrg3 response in the epidermis. Erbb1 is slightly more activated in the transgenic epidermis when compared to the non-transgenic epidermis (Fig. 3I). Both Erbb2 and Erbb3 activation levels are similar in the transgenic and non-transgenic epidermis (Fig. 3I). Ectopic Nrg3 promotes a slight increase in the levels of Erbb4 and a moderate increase in tyrosine phosphorylation of Erbb4 in the transgenic epidermis (Fig. 3I). The possible active signaling complexes in the transgenic epidermis are therefore Erbb1:1, Erbb1:2, Erbb1:3, Erbb2:3, Erbb2:4, Erbb4:4 since Erbb2 requires a Neuregulin binding receptor to signal and Erbb3 homodimers are inactive.
###end p 25
###begin p 26
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 134 140 134 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 632 638 632 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 776 782 776 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYT-1 </italic>
###xml 786 792 786 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CYT-2 </italic>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3J</xref>
###xml 919 928 919 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 JM </italic>
###xml 1069 1074 1069 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JM-a </italic>
###xml 1078 1082 1078 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JM-b</italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JM-a </italic>
###xml 1183 1188 1183 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">JM-b </italic>
###xml 1257 1259 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3J</xref>
###xml 1303 1308 1303 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1346 1355 1346 1355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 JM </italic>
Signaling through the Erbb4 receptor is complicated as four major variants of the receptor exist [40]. Alternative splice variants of Erbb4 are produced at two distinct sites resulting in four possible isoforms of the receptor. JM-a and JM-b variants encode variable extracellular juxtamembrane isoforms that can be cleaved by matrix metalloproteases (MMPs) (JM-a) or are resistant to such cleavage (JM-b) [41]. Two cytoplasmic variants also exist which contain (CYT-1) or lack (CYT-2) an exon corresponding to sixteen amino acids that encodes a phosphatidylinositol 3-kinase (PI3K) docking site [42]. We examined the expression of Erbb4 isoforms in the epidermis of three independent K14-Nrg3 transgenic lines and compared them to the epidermis from non-transgenic siblings. CYT-1 and CYT-2 isoforms were expressed at similar levels in both the transgenic and non-transgenic epidermis (Fig. 3J). We found that unusual Erbb4 JM isoform profiles exist in the transgenic epidermis that are distinct from those expressed in non-transgenic epidermis. Similar levels of the JM-a and JM-b isoforms are expressed in non-transgenic epidermis. We observed deviations such that either JM-a or JM-b isoforms were preferentially expressed in the transgenic lines (Fig. 3J). These results suggest that misexpressing Nrg3 in the epidermis alters the ratios of Erbb4 JM splice isoform gene expression.
###end p 26
###begin p 27
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3I</xref>
The JM-a domain of Erbb4 encodes a cleavable receptor which can transmit signals to the cytoplasm and nucleus [43-45]. Binding of Nrg1 to the Erbb4 JM-a ectodomain isoform results in the cleavage and shedding of the 120 kD ectodomain. This is mediated by tumor necrosis factor-alpha converting enzyme and results in the production of an 80 kD intracellular membrane-bound domain [46]. This domain can then be cleaved by gamma-secretase to release an 80 kD intracellular domain [47]. Immunoprecipitate analysis of Erbb4 receptor signaling detected no activated 80 kD isoform in the epidermis from transgenic or non-transgenic littermates (Fig. 3I). Therefore, activated Erbb4 exists predominantly in the 180 kD membrane-bound isoform in the epidermis of both transgenic and non-transgenic littermates (Fig. 3I).
###end p 27
###begin title 28
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
K14-Nrg3 transgenic mice exhibit other epithelial appendage phenotypes
###end title 28
###begin p 29
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 808 809 808 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 717 722 <span type="species:ncbi:10090">mouse</span>
We observed fewer K14-Nrg3 transgenic females than predicted and the overall efficiency of transgenesis was low (Additional File 3), suggesting that ectopic expression of Nrg3 in the epidermis during embryogenesis may be partially lethal, particularly in females. Four female transgenic founders with obvious skin phenotypes were obtained. Of these, two were found dead shortly after birth. Histological analysis showed a skin phenotype similar to that observed in the other male transgenic founders (data not shown). The other two female founders both displayed a hairless, wrinkled, thickened, pale skin similar to that observed in the male founders except this was present on approximately half of the body of the mouse, consistent with integration of the transgene at the two-cell stage (Additional File 4).
###end p 29
###begin p 30
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 291 296 291 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B, C</xref>
###xml 774 785 774 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4E, F, G, H</xref>
###xml 947 952 947 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D, E</xref>
###xml 1056 1061 1056 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4I, J</xref>
###xml 1163 1165 1163 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1173 1178 1173 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4I, J</xref>
###xml 610 614 <span type="species:ncbi:10090">mice</span>
###xml 816 831 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1139 1144 <span type="species:ncbi:10090">mouse</span>
At P12, these two female founders were scored for the number and placement of nipples on the ventral surface. In both females, in addition to the 5 pairs in the normal location (Fig. 4A), there were multiple ectopic nipples both along the "mammary line" and also in adjacent locations (Fig. 4B, C). Results from breeding from these females were consistent with chimerism. The one transgenic male pup produced in the first litter displayed the same hairless, wrinkled, thickened, pale skin phenotype (over its entire body surface) shared by the other transgenic founder males and died at P5. The female founder mice were culled to collect tissue samples for analysis and verify that mammary tissue (fat pad and epithelial ducts) was associated with the ectopic nipples (Fig. 4E, F, G, H). Ectopic nipples observed on transgenic mice are usually smaller than the endogenous nipples which are very large when compared to non-transgenic nipples (Fig. 4D, E) but varied considerably in size and are sometimes as large as the endogenous transgenic nipples (Fig. 4I, J). Both endogenous and ectopic nipples express Keratin2e, a nipple marker for mouse nipple epidermis [48] (Fig. 4I, J).
###end p 30
###begin p 31
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 0 106 0 106 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ectopic expression of <italic>Nrg3 </italic>in the epidermis results in the formation of ectopic nipples and mammary glands</bold>
###xml 109 110 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 344 345 344 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 640 641 640 641 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 794 795 794 795 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 879 880 879 880 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 897 902 897 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1134 1135 1134 1135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 1270 1271 1270 1271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1474 1475 1474 1475 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1601 1602 1601 1602 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I</bold>
###xml 1669 1674 1669 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1772 1773 1771 1772 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 1837 1842 1836 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Ectopic expression of Nrg3 in the epidermis results in the formation of ectopic nipples and mammary glands. (A) Ventral surface of non-transgenic littermate at P12 with the five pairs of nipples marked. Numbers denote the positions of the five normal nipples. External genitalia of female non-transgenic littermate is indicated with an arrow. (B) Ventral surface of one chimeric founder female at P12 with the five pairs of endogenous nipples boxed in bold, and ectopic nipples are marked with black boxes. Numbers denote the positions of the five normal nipples. Enlarged external genitalia of K14-Nrg3 female is indicated with an arrow. (C) Magnification of left side of (B) showing close-up of nipples which are denoted by arrows. Numbers denote the position of the endogenous nipples 1-3. (D) Non-transgenic nipples are small and round. Image acquired at 160x magnification.(E) Transgenic K14-Nrg3 nipples are very large and round. Ectopic nipples are usually smaller than the endogenous transgenic nipples and of a similar size to non-transgenic nipples. Ectopic nipple is indicated (ect). Image acquired at 160x magnification. (F) Carmine-stained whole-mount of mammary fat pad associated with ectopic nipple showing nipple (n) connected to a mammary ductal tree.(G) H&E-stained section of ectopic nipple showing associated mammary epithelial tissue. Endogenous nipple (n) and ectopic nipple (ect) are indicated and associated epithelial ducts are denoted by arrows. (H) H&E-stained section of fat pad and mammary ducts (indicated with arrows) associated with an ectopic nipple (shown in (G)). (I) K2e, a marker of nipple skin, is expressed in the endogenous K14-Nrg3 nipple skin. The primary mammary duct is indicated by an arrow. The scale bar represents 50 mum. (J) K2e, a marker of nipple skin, is expressed in the ectopic K14-Nrg3 nipple skin. The primary mammary duct is indicated by an arrow. The scale bar represents 50 mum.
###end p 31
###begin p 32
###xml 114 119 114 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A, B</xref>
###xml 129 134 129 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A, B</xref>
###xml 353 358 353 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C, D</xref>
###xml 481 486 481 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E, F</xref>
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
Both male and female mice exhibited enlarged external genitalia when compared to non-transgenic littermates (Fig. 4A, B and Fig. 5A, B). Despite the increased size of the external genitalia, most mice were fertile and could breed. Most transgenic founders displayed very sparse and wispy whiskers and one line eventually grew sparse and wavy hair (Fig. 5C, D). Clusters of hair follicles were observed in some skin sections, which is indicative of abnormal patterning events (Fig. 5E, F). One transgenic founder line exhibited premature tooth eruption (culled at P7 as it could no longer suckle) but normal tooth number and cusp patterning were observed in these and other transgenic founder lines (data not shown).
###end p 32
###begin p 33
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ectopic expression of <italic>Nrg3 </italic>in the epidermis causes defects in the external genitalia, vibrissae, and hair</bold>
###xml 108 109 108 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 193 194 193 194 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 281 282 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 377 378 377 378 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 397 402 397 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 632 633 632 633 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 755 756 755 756 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
###xml 593 597 <span type="species:ncbi:10090">mice</span>
Ectopic expression of Nrg3 in the epidermis causes defects in the external genitalia, vibrissae, and hair. (A) External genitalia of male non-transgenic littermate is indicated with an arrow. (B) Enlarged external genitalia of K14-Nrg3 transgenic male is indicated with an arrow. (C) Vibrissae of non-transgenic littermate are indicated with an arrow. Note normal fur growth. (D) Vibrissae of K14-Nrg3 transgenic mouse (indicated with an arrow) are sparse and wispy in comparison to non-transgenic littermate. In one K14-Nrg3 founder and most progeny from this line sparse fur appeared as the mice aged (usually from P100 onward). (E) Oil red O -stained section of skin from non-transgenic littermate at P7 showing normal distribution of hair follicles. (F) Oil red O -stained section of skin from K14-Nrg3 transgenic founder at P7 showing abnormally close juxtaposition of hair follicles which are indicated with arrows.
###end p 33
###begin title 34
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Hyperproliferative marker profile but a normal terminal differentiation profile observed in K14-Nrg3 transgenic interfollicular epidermis
###end title 34
###begin p 35
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 376 381 376 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A, B</xref>
###xml 518 519 518 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 660 665 660 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C, D</xref>
###xml 683 684 683 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1012 1017 1012 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1039 1044 1039 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E, F</xref>
###xml 1062 1063 1062 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 1187 1189 1187 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G</xref>
###xml 1243 1245 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1320 1325 1320 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6H</xref>
###xml 1499 1504 1499 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6G, H</xref>
###xml 1507 1509 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1640 1642 1640 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 2012 2017 2012 2017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
The status of epidermal differentiation was assessed using immunohistochemistry of paraffin sections. Although the epidermis is thicker in K14-Nrg3 skin compared to non-transgenic littermates, markers of terminal epidermal differentiation were present. The distribution of Filaggrin, a terminal differentiation marker, is maintained in the granular and cornified layers (Fig. 6A, B). Similarly Involucrin, another terminal differentiation marker is also expressed in the granular and cornified layers (Additional File 5). The distribution of K1 and K10, markers for committed early differentiating cells, are unaltered and remain in the suprabasal layer (Fig. 6C, D; Additional File 5). Neoplastic skin lesions generally display reduced K1 expression so the transgenic epidermis does not appear to be neoplastic. K5 and K14 were used as markers for the basal proliferating keratinocytes and showed markedly altered expression. Both were expressed at high levels throughout the basal and suprabasal layers of K14-Nrg3 transgenic skin (Fig. 6E, F; Additional File 5). Another basal keratin, K15 is normally restricted to basal keratinocytes as observed in non-transgenic littermates (Fig. 6G) and marks undifferentiated cells with low turnover [49]. K15 expression is reduced in the basal interfollicular epidermis in K14-Nrg3 basal epidermis (Fig. 6H). K15 expression is retained in the outer root sheath where it marks the bulge region of the hair follicle in both normal and mutant epidermis (Fig. 6G, H) [50]. K15 expression is not compatible with keratinocyte activation and is frequently downregulated in hyperproliferative conditions [51]. The large expansion of suprabasal and granular layers observed in transgenic skin is also a feature of hyperproliferating conditions. Ectopic expression of Nrg3 in the basal layer deregulates the expression pattern of keratin markers, K5, K14, and K15 to one associated with hyperproliferation conditions. The terminal differentiation program of keratinocytes in K14-Nrg3 transgenic skin is essentially normal and characterized by excessive production of terminally differentiated cells.
###end p 35
###begin p 36
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Immunohistochemistry using epidermal differentiation markers</bold>
###xml 212 214 212 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 218 219 218 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 389 391 389 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 395 396 395 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 521 526 521 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 548 550 548 550 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E </bold>
###xml 554 555 554 555 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 806 811 806 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 863 865 863 865 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G </bold>
###xml 869 870 869 870 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1088 1093 1088 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 115 130 <span type="species:ncbi:10090">transgenic mice</span>
Immunohistochemistry using epidermal differentiation markers. Immunohistochemistry of sections of dorsal skin from transgenic mice and non-transgenic littermates at P7 with antibodies to the proteins indicated. (A and B) Expression of Filaggrin, a terminal differentiation marker, is maintained in the granular and cornified layers of non-transgenic (A) and K14-Nrg3 transgenic (B) skin. (C and D) K1, a marker for committed early differentiating cells, is expressed in the suprabasal layer of non-transgenic (C) and K14-Nrg3 transgenic (D) skin. (E and F) K14, a marker for basal proliferating keratinocytes, is expressed in the basal layer of non-transgenic skin and the ORS of the hair follicles (E) and is expressed at high levels throughout the basal, suprabasal, granular and cornified layers of K14-Nrg3 transgenic skin and ORS of the hair follicles (F). (G and H) Expression of K15 is normally restricted to basal keratinocytes as observed in non-transgenic littermates (G) and marks undifferentiated cells with low turn over. Expression of K15 is reduced in the basal IFE in K14-Nrg3 basal epidermis (H). K15 is expressed in the ORS, where it marks the bulge region of the hair follicle, in both normal and mutant epidermis (G and H). Basal expression of K15 in the IFE and ORS is denoted by arrows. The scale bar represents 50 mum.
###end p 36
###begin title 37
Nrg3 signaling stimulates epidermal proliferation
###end title 37
###begin p 38
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 623 625 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7E</xref>
###xml 791 796 791 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
The increased thickness of the epidermis suggested that Nrg3 stimulates proliferation. Ki67 was used as a proliferation marker for cells (expressed by cells in late G1, S, G2, and M phases). In contrast to normal skin (Fig. 7A), the K14-Nrg3 basal cells are nearly all Ki67+ and many suprabasal cells are Ki67+ (Fig. 7B). In one K14-Nrg3 transgenic line, approximately 43% of the interfollicular epithelial cells are Ki67+ compared to 26% observed in non-transgenic littermates in postnatal day 7 skin (Fig. 7C). Normally, a restricted number of basal cells express CyclinD1 (which is expressed by cells in G1 phase) (Fig. 7D). However, CyclinD1 expression is observed in the basal, suprabasal, and granular cell layers of K14-Nrg3 epidermis (Fig. 7E). Therefore, constitutive expression of Nrg3 increases the number of cycling cells in the epidermis, including the basal layer.
###end p 38
###begin p 39
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased proliferation in K14-<italic>Nrg3 </italic>epidermis</bold>
###xml 134 136 134 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 140 141 140 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 323 324 323 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 586 588 586 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D </bold>
###xml 592 593 592 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 690 695 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Increased proliferation in K14-Nrg3 epidermis. Immunohistochemical analysis shows an increase in Ki67 and CyclinD1 in the epidermis. (A and B) In non-transgenic epidermis (A), Ki67 is restricted to some basal cells. In K14-Nrg3 skin (B), Ki67 is expressed throughout the basal layer and in three to four suprabasal layers.(C) Quantification of immunohistochemical analysis with Ki67 antibodies. 500 cells were counted. Error bars indicate the standard deviation. The differences are significant between non-transgenic and K14-Nrg3 epidermis (p = 0.0176) using the paired student test. (D and E) In non-transgenic epidermis (D), CyclinD1 expression is restricted to some basal cells. In K14-Nrg3 skin (E), CyclinD1 is expressed throughout most of the IFE. The scale bar represents 50 mum.
###end p 39
###begin title 40
Sustained Nrg3 signaling stimulates sebocyte differentiation
###end title 40
###begin p 41
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 744 746 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 747 749 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 814 819 814 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 954 959 954 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8E, F</xref>
###xml 1036 1041 1036 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1102 1104 1102 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8G</xref>
###xml 434 438 <span type="species:ncbi:10090">mice</span>
To examine the differentiation of sebaceous glands, we stained transgenic and non-transgenic skin with Oil Red O, which marks lipid- containing cells, including sebocytes. In normal skin, sebaceous glands were associated with the upper part of each hair follicle (Fig. 8A). In K14-Nrg3 transgenic skin, the number and size of sebocytes was greatly increased (Fig. 8B). This is especially dramatic in skin samples collected from older mice, where essentially all of the abnormal hair follicles are filled with sebocytes and only few structures resembling hair follicles remain (Fig. 8D). This suggests that Nrg3 signaling stimulates sebocyte differentiation. Several studies have shown that c-Myc activation stimulates sebocyte differentiation [52,53], and therefore we examined c-Myc expression. We found that K14-Nrg3 transgenic skin exhibited increased c-Myc expression through most of the basal layer when compared to non-transgenic littermates (Fig. 8E, F). Western blot analysis confirmed an increase in the levels of c-Myc in K14-Nrg3 transgenic skin compared to non-transgenic littermates (Fig. 8G)
###end p 41
###begin p 42
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 signaling stimulates sebocyte differentiation</bold>
###xml 53 55 53 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 270 271 270 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 338 339 338 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 451 453 451 453 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E </bold>
###xml 457 458 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 669 670 669 670 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 771 776 771 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Nrg3 signaling stimulates sebocyte differentiation. (A and B) In non-transgenic epidermis (A), Oil Red O stains the sebaceous gland (indicated by arrows) associated with each hair follicle. In K14-Nrg3 skin (B), the sebaceous glands (indicated by arrows) are enlarged. (C) Section stained with H&E from non-transgenic littermate at P52. (D) Section stained with H&E from K14-Nrg3 transgenic skin at P52. Note the excessive sebaceous differentiation. (E and F) In non-transgenic epidermis (E), c-Myc expression is restricted to a few basal cells (indicated by arrows). In K14-Nrg3 skin (F), it is expressed throughout most of the basal epidermis (indicated by arrows). (G) Western blot for c-Myc. Lysates were prepared from ventral skin of non-transgenic (lane 1) and K14-Nrg3 littermates (lane 2) and blotted with antibodies against c-Myc and beta-Tubulin (loading control). The scale bar represents 50 mum.
###end p 42
###begin title 43
Sustained Nrg3 signaling perturbs basement membrane organization
###end title 43
###begin p 44
###xml 222 227 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 287 292 281 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9A, B</xref>
###xml 342 344 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 386 391 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 451 462 441 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9C, D, E, F</xref>
###xml 900 902 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9G</xref>
###xml 989 994 972 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1005 1007 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9H</xref>
The extracellular matrix receptor, beta1-integrin, is preferentially expressed in many epidermal stem cells and thought to be required to maintain the stem cell compartment. beta1-integrin exhibits reduced staining in K14-Nrg3 epidermis when compared to non-transgenic littermates (Fig. 9A, B). The hemidesmosomal component, alpha6-integrin [54], also displayed reduced staining in K14-Nrg3 epidermis when compared to non-transgenic littermates (Fig. 9C, D, E, F). Strong adhesion of the basal cells to the underlying basal lamina is provided by the hemidesmosomes. The aberrant staining of cell adhesion markers, alpha6-integrin and beta1-integrin, suggest that partial dissolution of underlying basement membrane has occurred. Tenascin-C, an adhesion-modulating extracellular matrix glycoprotein, is expressed along the basement membrane in the vicinity of hair follicles in normal epidermis (Fig. 9G). There is significant upregulation of Tenascin-C within the basement membrane of K14-Nrg3 skin (Fig. 9H).
###end p 44
###begin p 45
###xml 0 92 0 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 signaling perturbs the expression of basement membrane components and stem cell markers</bold>
###xml 95 97 95 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A </bold>
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 297 302 291 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 329 331 323 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C </bold>
###xml 335 336 329 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 515 520 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 806 808 784 786 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G </bold>
###xml 812 813 790 791 <bold xmlns:xlink="http://www.w3.org/1999/xlink">H</bold>
###xml 1035 1040 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1186 1188 1164 1166 <bold xmlns:xlink="http://www.w3.org/1999/xlink">I </bold>
###xml 1192 1193 1170 1171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">J</bold>
###xml 1535 1540 1513 1518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Nrg3 signaling perturbs the expression of basement membrane components and stem cell markers. (A and B) beta1-integrin is expressed along the basement membrane (indicated by an arrow) throughout the basal epidermis of non-transgenic littermate (A). beta1-integrin expression is reduced in the K14-Nrg3 transgenic epidermis (B). (C and D) alpha6-integrin is expressed along the basement membrane throughout the basal epidermis of non-transgenic littermate (C and E). alpha6-integrin expression is reduced in the K14-Nrg3 transgenic epidermis (D and F). The basement membrane expression is indicated by an arrow. Some regions of intact basement membrane are present with normal levels of alpha6-integrin expression, indicated by dashed line, adjacent to regions where alpha6-integrin expression is reduced. (G and H) Tenascin-C is expressed along the basement membrane in the vicinity of hair follicles of non-transgenic littermate and is indicated by an arrow (G). Tenascin-C is expressed along the basement membrane throughout the K14-Nrg3 transgenic basal epidermis (H). Strong Tenascin-C staining expression is observed at the dermal-epidermal junction and is indicated by an arrow. (I and J) p63 expression is restricted to epidermal and hair follicle cells with high proliferative potential and is absent in cells undergoing terminal differentiation. p63 expression is restricted to most basal cells and a few suprabasal cells in the IFE and ORS of non-transgenic littermates (I). p63 is expressed throughout most of the basal K14-Nrg3 epidermis (J) with expanded expression detected in up to four suprabasal cell layers. The scale bar represents 50 mum except in (E and F) where it represents 12.5 mum.
###end p 45
###begin title 46
Nrg3 activity regulates the fate of epidermal progenitor cells
###end title 46
###begin p 47
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 452 457 452 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9I, J</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9J</xref>
###xml 566 568 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 820 825 820 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
p63 is normally expressed in most basal epidermal cells and some suprabasal cells and is thought to act to maintain the proliferative potential of stem cells and to mediate epidermal differentiation [55-57]. p63 is expressed in cells with high proliferative potential and is absent in cells undergoing terminal differentiation. We observed expanded expression of p63 which was detected in up to four suprabasal cell layers in K14-Nrg3 epidermis. (Fig. 9I, J). A similar distribution of Ki67+ and p63+ cells was observed in the suprabasal layers (compare Figs 9J and 7B). By definition, stem cells rarely cycle and the transit-amplifying cells are actively cycling [58]. This suggests that an increased number of quiescent stem cells are recruited into cell cycle and enter into the transit-amplifying compartment in K14-Nrg3 epidermis. Transit-amplifying cells divide several times to produce differentiated cells, which leads to terminal differentiation along various lineages. These results suggest that Nrg3 can influence epidermal stem cell fate decisions and, when ectopically expressed in the basal epidermis, Nrg3 promotes the differentiation of stem cells into epidermal and sebaceous lineages and not along the hair lineage.
###end p 47
###begin title 48
Discussion
###end title 48
###begin p 49
###xml 165 166 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
###xml 955 957 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 812 827 <span type="species:ncbi:10090">transgenic mice</span>
We have shown that sustained expression of Nrg3 in the basal epidermis alters the development of epidermal organs including the skin, hair, and mammary glands (Figs 1, 2, 4). Modulation of Nrg3 signaling affects the number of mammary glands by promoting initiation. We have not observed the induction of other ectopic organs in the K14-Nrg3 founders aside from mammary glands. However, ectopic Nrg3 did increase the size and alter the shape of most epithelial appendages, which is suggestive of morphogenetic changes. Failure of proper hair differentiation occurred and, in the few cases where hair fibers formed and emerged, only one hair type, zigzag, developed (Fig. 2). Our observation of clusters of hair follicles suggests that in some regions, normal patterning is perturbed (Fig. 5F). In skin from older transgenic mice, the entire hair follicle structure is filled with sebocytes suggesting alterations in cell fate decisions have occurred (Fig. 8D).
###end p 49
###begin p 50
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 9 24 <span type="species:ncbi:10090">transgenic mice</span>
###xml 880 885 <span type="species:ncbi:10090">mouse</span>
K14-Nrg3 transgenic mice form extra nipples associated with mammary ducts (Fig. 4). The extra mammary glands develop along and close to the mammary line. Although K14 is expressed in the epidermis from E9.5, it is not upregulated until E14.5 when strong K14 expression is observed in the basal layer of the epidermis, in the outer root sheath and in the bulge cells [37]. K14 upregulation therefore occurs after the mammary placodes have already formed. Our K14-Nrg3 transgenics were low copy number integrants and expressed low-levels of the transgene and it is possible that higher levels of expression might elicit other phenotypic effects if it were not lethal. Our previous studies demonstrated both epidermal stratification (the first indication of mammary placode development) and placode formation adjacent to sites of ectopically delivered recombinant Nrg3-Egf domain in mouse embryo explant cultures [2]. The results reported here suggest that, at least in some cases, these ectopic placodes have the ability to complete the entire mammary morphogenetic program.
###end p 50
###begin p 51
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 949 950 949 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1198 1200 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1326 1331 1326 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1412 1417 1412 1417 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
All four Erbb receptors are expressed in the developing mouse epidermis providing a wide range of signaling possibilities as well as compensatory mechanisms (Fig. 3). Depending on the ligand and the availability of dimerization partners these receptors will then transmit quantitatively or qualitatively different signals in different cell types [59,60]. No significant elevations in Egfr, Erbb2, or Erbb3 were observed as assessed by immunohistochemistry and western blot (Fig. 3 and data not shown). Phosphotyrosine levels were used to assess the activation status of each receptor (Fig. 3). Erbb1 appeared to have slightly increased phosphotyrosine content in the transgenic epidermis. Erbb2, and Erbb3 were active at similar levels in both the transgenic and non-transgenic epidermis. Erbb4 is not normally expressed at significant levels in the postnatal interfollicular epidermis but is expressed throughout the K14-Nrg3 transgenic skin (Fig. 3). We observed increased levels of Erbb4 and tyrosine phosphorylation of Erbb4 in the transgenic epidermis when compared to non-transgenic littermates. This is consistent with previous reports that Erbb4 homodimers are the major receptor for Nrg3 [61]. It is likely that cellular mechanisms exist to prevent autocrine signaling of Nrg3-Erbb4, which can be overcome in the K14-Nrg3 transgenic model. Our findings suggest that increased Erbb4 signaling in the K14-Nrg3 transgenic skin underlies the striking epidermal phenotypes observed in this transgenic model.
###end p 51
###begin p 52
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 203 204 203 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4</italic>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 451 457 451 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 512 513 512 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 559 565 559 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 871 872 871 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 909 914 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb2</italic>
###xml 967 968 967 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 969 970 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1124 1133 1124 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 1322 1326 1322 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg1</italic>
###xml 1333 1338 1333 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb2</italic>
###xml 1349 1354 1349 1354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4</italic>
###xml 1516 1518 1516 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1519 1521 1519 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1604 1609 1604 1609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4</italic>
###xml 1631 1636 1631 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb2</italic>
###xml 1734 1736 1734 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1737 1739 1737 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 2014 2016 2014 2016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 2017 2019 2017 2019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 2136 2138 2136 2138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 2370 2372 2370 2372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 2444 2446 2444 2446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 2581 2583 2581 2583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 2799 2801 2799 2801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 2802 2804 2802 2804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 920 924 <span type="species:ncbi:10090">mice</span>
###xml 1360 1364 <span type="species:ncbi:10090">mice</span>
###xml 1615 1619 <span type="species:ncbi:10090">mice</span>
###xml 1642 1646 <span type="species:ncbi:10090">mice</span>
Erbb2 is the preferred heterodimerization partner for all of the Erbb receptors [62], so it is likely that Nrg3 elicits its effects through both Erbb2-Erbb4 heterodimers and Erbb4-Erbb4 homodimers (Fig. 3). Normal mammary ductal outgrowth occurs, but lactation fails in mammary glands from both heart-rescued Erbb4-null mice (where a myocardial promoter restores Erbb4 expression to the heart and overcomes embryonic lethality) and from mice in which Erbb4 has been conditionally deleted from the mammary gland [3,4]. Lobular-alveolar units from mice lacking Erbb4 in the mammary gland do not express markers of terminal differentiation and exhibit deficient proliferation of the mammary epithelium during pregnancy and at partuition. Erbb4 signaling appears to be required for secretory maturation of the alveoli since milk genes are expressed albeit at reduced levels [3]. Mammary glands from heart-rescued Erbb2-null mice display mammary ductal outgrowth defects [7,8]. Nrg1 signaling through Erbb2-Erbb4 heterodimers is required to elicit Stat5 activation and neither Erbb2 nor Erbb4 homodimers alone can activate Stat5 in vitro [63]. These results suggest that signaling through Erbb2-Erbb4 heterodimers is likely to be required to achieve terminal differentiation of the mammary gland, but not for ductal outgrowth. Nrg1-null, Erbb2-null, and Erbb4-null mice all display myocardial trabeculation defects which indicates that Nrg1 signaling through Erbb2- Erbb4 heterodimers is necessary for heart development [64-66]. Distinct neural defects including mis-innervation of the hindbrain are found in Erbb4-null mice and not in Erbb2-null mice, which suggests that this signaling occurs without utilizing Erbb2-Erbb4 heterodimers [64,65]. Erbb4 signaling regulates many other developmental pathways including the migration and differentiation of neuroblasts in the rostral-nasal stream, inhibiting cortical astrogenesis, hypothalamus-mediated reproductive development and function, and blastocyst implantation [67-71]. Signaling through Erbb4 is generally associated with cellular differentiation, particularly in the mammary gland [72]. Erbb4 signaling is likely to be far more complex since active membrane-bound, nuclear and cytosolic forms of Erbb4 exist and have been associated with other cellular processes, including apoptosis and transcriptional repression [73]. Erbb2-Erbb4 heterodimers have higher affinity than Erbb4 homodimers [74]. Signaling through Erbb heterodimers is thought to result in more potent mitogenic response than signalling through Erbb homodimers [75]. Erbb2 can bind to more phosphotyrosine binding proteins, and signaling through Erbb2-Erbb4 heterodimers is generally thought to result in more diverse and distinct outputs than signaling through Erbb4 homodimers [75,76].
###end p 52
###begin p 53
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 JM </italic>
###xml 356 362 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 564 566 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 644 650 644 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
We observed unusual Erbb4 JM variant profiles in the transgenic epidermis that are distinct from those observed in non-transgenic littermates. Two recent studies have shown that both the CYT-1 isoform and JM-a isoform are overexpressed in the dorsolateral frontal cortex of schizophrenic patients and suggest that dysregulated splice variant expression of Erbb4 may underlie the genetic association of Erbb4 with schizophrenia [77,78]. The four different isoforms of Erbb4 have different signaling capabilities and may mediate distinct biological functions [42,43,79]. The contribution of dysregulation of splice-variant specific expression of Erbb4 in the K14-Nrg3 transgenic skin to the phenotype we observe remains to be elucidated.
###end p 53
###begin p 54
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 240 242 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 243 245 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 328 330 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 344 346 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 376 378 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 432 437 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
The postnatal K14-Nrg3 hyperplastic epidermal phenotypes are likely to result from induction of signaling pathways that are not normally continuously activated. Since both c-Myc and CyclinD1 are downstream target genes of beta-catenin/Lef [80,81] and the Wnt pathway has well-established roles in both epithelial proliferation [82], cell fate [83], and stem cell maintenance [84], we examined Wnt/beta-catenin expression in the K14-Nrg3 epidermis. However, we did not detect nuclear beta-catenin, altered membranous beta-catenin or E-cadherin stain or changes in Lef1 expression in the transgenic epidermis (data not shown).
###end p 54
###begin p 55
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 171 172 164 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 385 387 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 388 390 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 508 510 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 511 513 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 617 619 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
###xml 721 723 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 724 726 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
###xml 989 990 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 993 995 973 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B91">91</xref>
###xml 996 998 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 398 403 <span type="species:ncbi:9606">human</span>
###xml 408 413 <span type="species:ncbi:10090">mouse</span>
###xml 549 554 <span type="species:ncbi:9606">human</span>
K14-Nrg3 epidermis displays features indicative of perturbed basement membrane organization, including reductions in alpha6-integrin and beta1-integrin expression levels (9). alpha6-integrin and beta1-integrin are cell surface molecules that mediate cell attachment and keratinocyte migration. Both are highly expressed in stem cells and likely to have roles in stem cell maintenance [85,86]. Both human and mouse epidermal stem cells are more adhesive to the extracellular matrix than their daughter cells [86,87]. Reduced beta1-integrin levels in human keratinocytes stimulates exit from the stem cell compartment [88]. beta1-integrin is required for basement membrane remodelling and for downgrowth of hair follicles [89,90]. Transgenic expression of Nrg3 within the basal epidermis also induces Tenascin-C, an adhesion-modulating extracellular matrix glycoprotein, which is often found at the sites of epithelial-mesenchymal interactions during development and tissue remodeling (Fig. 9) [91,92]. These results suggest that Nrg3 signaling elicits adhesive and extracellular matrix changes that are likely to have significant consequences on progenitor cell behaviour and morphogenetic events.
###end p 55
###begin p 56
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 382 387 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 398 399 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3</italic>
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B98">98</xref>
###xml 648 653 648 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F9">9</xref>
###xml 836 842 836 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1014 1016 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1017 1019 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 1120 1122 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 1316 1321 1309 1314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 1329 1335 1322 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 1347 1353 1340 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 1461 1463 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1353 1357 <span type="species:ncbi:10090">mice</span>
A number of studies have demonstrated that transgenic expression of c-Myc in the basal cells of the epidermis promotes the differentiation of epidermal stem cells into sebaceous glands. This is a strikingly similar phenotype to our observations in the K14-Nrg3 postnatal epidermis [52,53,93]. Consistent with this similarity, c-Myc expression is increased in the basal layer of K14-Nrg3 skin (Fig. 8) and changes in K14-Nrg3 epidermis such as hyperproliferation and increase in cell size (Fig. 2) are consistent with the increased basal expression of c-Myc [94-98]. The extension of expression of p63 into a large number of suprabasal cells in K14-Nrg3 skin (Fig. 9) suggests that Nrg3 might cause epidermal cells to exit the stem cell compartment and stimulate the proliferation of transit-amplifying cells, as is also observed in K14-c-Myc transgenic skin [53]. Also consistent with c-Myc activation is the decreased alpha6-integrin and beta1-integrin expression observed throughout most of the basal epidermis [52,93]. c-Myc-induced repression of adhesion is thought to stimulate epidermal stem cell differentiation [93]. Our data implies that Nrg3 can alter the proliferation status of basal epidermal cells, most likely, through the induction of c-Myc. However, there are important distinctions between the K14-Nrg3 and K14-c-Myc models. K14-c-Myc mice do form hair which is gradually lost and other epithelial appendage phenotypes have not been reported [52].
###end p 56
###begin p 57
###xml 661 663 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 664 666 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B99">99</xref>
###xml 667 670 660 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B101">101</xref>
###xml 732 738 725 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 873 879 866 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 890 893 883 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B102">102</xref>
###xml 920 926 913 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 1050 1053 1043 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B103">103</xref>
###xml 1209 1215 1202 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 1225 1228 1218 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B104">104</xref>
###xml 1255 1259 1248 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rac1</italic>
###xml 1285 1291 1278 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 1406 1409 1399 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B105">105</xref>
###xml 727 731 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
These results confirm our previous studies that Nrg3 signaling can regulate epithelial cell fate during mammary gland morphogenesis and suggest Nrg3 can also regulate other pluripotent cell populations in the epidermis. Of particular interest is the ability of Nrg3 to decrease alpha6-integrin and beta1-integrin expression, as this could be the mechanism by which Nrg3 normally elicits epithelial stratification and mammary differentiation at unique sites along the body axes during early mammary morphogenesis. Alterations in basement membrane components are known to have profound effects on progenitor populations perhaps by disrupting the stem cell niche [93,99-101]. The niche is also significantly altered in transgenic MMTV-c-Myc mammary epithelia, which show similar changes in stem cell retention and transit-amplifying cell fate decisions as observed in the K14-c-Myc epidermis [102]. Conditional deletion of c-Myc in the epidermis leads to precocious differentiation and loss of the basal progenitor cells through insufficient expansion [103]. Interestingly, another regulator of Erbb signaling, Lrig, an Egfr antagonist, acts to maintain stem cell quiescence in part by negatively regulating the c-Myc promoter [104]. Conditional deletion of Rac1, a negative regulator of c-Myc leads to rapid depletion of the stem cell compartment and highlights their critical roles in stem cell regulation [105].
###end p 57
###begin p 58
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 288 293 288 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 669 675 669 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c-Myc </italic>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 809 812 809 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B106">106</xref>
###xml 813 816 813 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B107">107</xref>
###xml 528 533 <span type="species:ncbi:9606">human</span>
We propose that when Nrg3 is ectopically expressed in to the postnatal period, as in the K14-Nrg3 model, the transit-amplifying cells may differentiate to form the interfollicular epidermis and sebaceous lineages by effectively the same means as proposed by Arnold and Watt [53] and Frye et al. [53,93] for the role of c-Myc in the epidermis. In this model, sustained c-Myc activation promotes sebaceous formation at the expense of the hair lineage; sustained Nrg3 expression appears to elicit the same effect. c-Myc expressing human keratinocytes exhibit decreased cell motility [93] which could explain the failure of the hair lineage differentiation in both the K14-c-Myc and K14-Nrg3 models. Keratinocytes must migrate out from the bulge down to receive the hair inductive signal from the dermal papilla [106,107]. It appears that the sebaceous lineage is conferred on keratinocytes that fail to migrate to the dermal papilla and remain in the bulge.
###end p 58
###begin p 59
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B108">108</xref>
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B109">109</xref>
###xml 315 318 315 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B110">110</xref>
###xml 380 383 380 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B111">111</xref>
###xml 384 387 384 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B112">112</xref>
###xml 418 421 418 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B113">113</xref>
###xml 422 425 422 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B114">114</xref>
###xml 672 675 672 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B113">113</xref>
###xml 676 679 676 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B114">114</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 821 823 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
The exact mechanism by which mammalian epithelia stratifies is not known but p63 is central to this process as stratification fails in its absence [56,108,109]. Recently p63 has been implicated as a key regulator of cellular adhesion and survival of basal cells in the mammary gland and other stratified epithelia [110]. Two models have been proposed (citing either delamination [111,112] or asymmetric cell division [113,114]) for how the stratification of epithelia is elicited. To what degree these contribute to epithelial morphogenesis remains to be ascertained. The onset of stratification during embryogenesis is thought to be elicited by asymmetric cell division [113,114]. Mammary placodes are thought to arise as a result of local cell migration [30] but, initial stages are characterized by stratification [31,32], which is thought to be elicited by basal cell proliferation.
###end p 59
###begin p 60
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B115">115</xref>
###xml 233 236 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B118">118</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B117">117</xref>
###xml 741 744 741 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B116">116</xref>
###xml 953 958 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
Changes in the adhesive properties of epithelial cells have been described as a general phenomena during the very early stages of bud formation of other organs including the hair follicle, submandibular gland, and mammary gland [115-118]. Both desmosomal and hemidesmosomal expression profiles are downregulated during early mammary bud formation and thought to mediate differences in cell adhesive properties within the forming bud which are subsequently restored during later stages of mammary gland formation [117]. It has been hypothesized that epithelial cells that form the hair follicle respond to the inductive signals from the dermal mesenchyme by changing their cell adhesion properties and that this mediates early morphogenesis [116]. Whether similar changes in adhesive processes are relevant to the very early stages of mammary development (i.e. the initial stratification and placode formation) remain to be determined. The expression of Nrg3 in the dermal mesenchyme at the sites where mammary placodes will form prior to their morphological appearance and the ability of Nrg3 to elicit placode formation in explanted embryo cultures would suggest Nrg3 could mediate changes in the adhesive components of the epithelium that lead to formation of the mammary placode.
###end p 60
###begin title 61
Conclusion
###end title 61
###begin p 62
Nrg3 is a key regulator of mammary fate. Ectopic expression of Nrg3 induces the formation of supernumerary mammary glands, the expression of c-Myc, and promotes sebaceous gland fate rather than along the hair follicle lineage. Deregulated Nrg3 expression in stem cells reduces the expression of alpha6-integrin and beta1-integrin, both of which are essential for stem cell maintenance and keratinocyte migration. Nrg3 may have roles in promoting mammary lineage commitment and regulation of stem cell maintenance via c-Myc. Further studies of Nrg3 are warranted to discern how mammary epithelial stratification is elicited, particularly with regard to how it coordinates interactions with other signaling pathways and to what degree basal epithelial proliferation contributes to this process.
###end p 62
###begin title 63
Methods
###end title 63
###begin title 64
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Generation of K14-Nrg3 mice
###end title 64
###begin p 65
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 317 322 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 13 18 <span type="species:ncbi:10090">mouse</span>
###xml 102 106 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 244 259 <span type="species:ncbi:10090">Transgenic mice</span>
The cDNA for mouse Nrg3 was excised and cloned into the ClaI and SpeI sites of K14-beta-globin and an SV40 polyadenylation site was added. The transgene was released from the vector with KpnI and microinjected into fertilized B6 x CBA F1 eggs. Transgenic mice were identified by Southern blotting of tail DNA using a Nrg3 cDNA probe.
###end p 65
###begin title 66
Histology, Immunohistochemistry and Immunoflourescence
###end title 66
###begin p 67
Skin samples were fixed overnight in 4% paraformaldehyde, formalin, or Carnoy's and then paraffin embedded or embedded in OCT and then frozen immediately in an isopentane bath. Sections (5 mum) were rehydrated, processed with microwave or pressure cooker antigen retrieval if required, and blocked and were incubated with primary antibodies overnight at room temperature.
###end p 67
###begin p 68
###xml 63 69 <span type="species:ncbi:9986">rabbit</span>
###xml 151 158 <span type="species:ncbi:9986">rabbits</span>
###xml 175 181 <span type="species:ncbi:9793">donkey</span>
###xml 187 191 <span type="species:ncbi:9925">goat</span>
###xml 271 275 <span type="species:ncbi:9925">goat</span>
###xml 346 350 <span type="species:ncbi:9925">Goat</span>
###xml 416 419 <span type="species:ncbi:10116">Rat</span>
###xml 443 448 <span type="species:ncbi:10090">Mouse</span>
###xml 497 500 <span type="species:ncbi:10116">rat</span>
###xml 528 534 <span type="species:ncbi:9986">rabbit</span>
###xml 540 545 <span type="species:ncbi:9940">sheep</span>
###xml 603 608 <span type="species:ncbi:9940">sheep</span>
###xml 669 674 <span type="species:ncbi:10090">mouse</span>
For immunohistochemistry, peroxidase-labeled polymer (Envision rabbit, Dako, Glostrup, Denmark) was used for detection of primary antibodies raised in rabbits. Biotin-labeled donkey anti-goat IgG antibody (Molecular Probes, Eugene, OR, USA) was used for detection of the goat antibodies using Vector ABC kit (Vector Labs, Burlingame, CA, USA) or Goat Histofine Simple Stain MAX PO (Nicherei, Chou-ku, Tokyo, Japan). Rat Histofine Simple Stain Mouse MAX PO (Nicherei) was used for detection of the rat antibodies. Biotin-labeled rabbit anti-sheep IgG antibody (Vector Labs) was used for detection of the sheep antibodies. MOM kit (Vector Labs) was used for detection of mouse monoclonal antibodies. 3,3' diaminobenzidine was used as chromagen and sections were counterstained with hematoxylin.
###end p 68
###begin p 69
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
The primary antibodies, dilutions, and antigen retrieval conditions used for immunohistochemistry are listed in Additional File 6.
###end p 69
###begin p 70
###xml 136 139 <span type="species:ncbi:10116">rat</span>
For immunoflourescence, alpha6 integrin antibody (BD Pharmingen) was used on frozen sections at 1:5 dilution followed by secondary anti-rat (Invitrogen, Molecular Probes) antibody conjugated to Alexa Fluor 488 fluorochrome. Nuclei were labeled by using 4'6'-diamidino-2-phenylindole (DAPI). Sections were mounted in Vectashield. Fluorescence samples were examined at room temperature using a TCS SP2 Leica microscope with an Acousto-Optical Beam Splitter.
###end p 70
###begin p 71
###xml 62 65 62 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B119">119</xref>
###xml 80 88 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
Oil Red O staining was performed using the standard protocol [119]. Whole mount in situ hybridization was performed with Nrg3 probe as previously described [2].
###end p 71
###begin title 72
Western blots
###end title 72
###begin p 73
###xml 516 522 <span type="species:ncbi:9986">rabbit</span>
Skin samples were homogenized with a Polytron in modified RIPA buffer (50 mM Tris-HCl pH 7.4, 1% Triton X-100, 0.2% sodium deoxycholate, 0.2% SDS, 1 mM EDTA) with protease inhibitors (1 mM PMSF, 5 mug/ml aprotinin, 5 mug/ml leupeptin, 1 mM NaF, 1 mM orthovanadate, 1 mM DTT). Homogenates were analyzed on 10% polyacrylamide gels and transferred to Hybond C extra membranes (GE Healthcare). Filters were incubated with anti-c-Myc (Upstate) overnight at 4degreesC, washed and incubated with peroxidase-conjugated anti-rabbit IgG (GE Healthcare) and visualized with enhanced chemiluminescence detection kit (ECL, GE Healthcare).
###end p 73
###begin title 74
Immunoprecipitation
###end title 74
###begin p 75
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B120">120</xref>
Erbb receptor phosphorylation was detected by immunoprecipitating lysates from skin samples with individual receptors and immunoblotting as described [120].
###end p 75
###begin title 76
RT-PCR
###end title 76
###begin p 77
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 266 267 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 630 636 592 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 790 796 752 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Erbb4 </italic>
###xml 937 943 899 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 970 976 932 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
Erbb4 isoform levels were determined by semiquantitative RT-PCR. cDNAs from transgenic and non-transgenic skin samples were analyzed for Erbb4 mRNA variants. A 1.0-muL portion of each cDNA was used as a template in PCR containing 0.3 muM of each primer, 2.25 mM MgCl2, 0.5 mM of each dNTP, and 2.5 U of Expand long template enzyme mix (Roche). The amplification conditions were 92degreesC for 2 min, followed by 35 cycles of 10 sec at 92degreesC, 30 sec at 57degreesC (for JM) or 63degreesC (for CYT), 3 min at 68degreesC, and a final step of 7 min at 68degreesC. The following primers were used to amplify the CYT variant of the Erbb4 coding region: Erbb4CYTF, GCTGAGGAATATTTGGTCCCCCAG; Erbb4CYTR, AAACATCTCAGCCGTTGCACCCTG. The following primers were used to amplify the JM variant of the Erbb4 coding region: Erbb4JMF, GAAATGTCCAGATGGCCTACAGGG; Erbb4JMR, CTTTTTGATGCTCTTTCTTCTGAC. Specificity was verified by sequencing. As a control, Gapdh was amplified in parallel. Gapdh levels were also determined by semiquantitative RT-PCR.
###end p 77
###begin title 78
Abbreviations
###end title 78
###begin p 79
Egfr, EGF receptor; HRG, Heregulin; K14, Keratin14; Nrg3, Neuregulin3.
###end p 79
###begin title 80
Competing interests
###end title 80
###begin p 81
The author(s) declares that there are no competing interests.
###end p 81
###begin title 82
Authors' contributions
###end title 82
###begin p 83
HP collected tissues, carried out immunohistochemistry, molecular and morphological analysis. OS and SP carried out tissue sectioning and immunohistochemistry. AA participated in the design of the study and helped draft the manuscript. BH conceived and coordinated the study, assisted with experiments, and wrote the manuscript. Figures were prepared by HP and BH. All authors read and approved the final manuscript.
###end p 83
###begin title 84
Supplementary Material
###end title 84
###begin title 85
Additional file 1
###end title 85
###begin p 86
Shows Nrg3 and Erbb4 expression in the hair follicles.
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Additional file 2
###end title 88
###begin p 89
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 68 83 <span type="species:ncbi:10090">transgenic mice</span>
Shows results from PCR genotyping of founder generation of K14-Nrg3 transgenic mice.
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 3
###end title 91
###begin p 92
Shows the efficiency of transgenesis for males versus females.
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Additional file 4
###end title 94
###begin p 95
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nrg3 </italic>
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Shows the phenotype of a chimeric K14-Nrg3 founder mouse.
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Additional file 5
###end title 97
###begin p 98
Shows results of analysis of transgenic skin using immunohistochemistry of epidermal differentiation markers.
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Additional file 6
###end title 100
###begin p 101
Is a list of antigen retrieval methods used for the immunohistochemistry.
###end p 101
###begin p 102
Click here for file
###end p 102
###begin title 103
Acknowledgements
###end title 103
###begin p 104
###xml 98 113 <span type="species:ncbi:10090">transgenic mice</span>
This work was funded by Breakthrough Breast Cancer. We thank Vladimir Grigoriev for generation of transgenic mice, staff of the ICR BSU for animal care, Jorge Reis-Filho for help with pathological analysis, Michelle James, Kay Savage, and Dawn Steele for excellent assistance with histopathology, Dave Robertson for assistance with confocal microscopy, and Carrie Ambler for helpful suggestions.
###end p 104
###begin article-title 105
Untangling the ErbB signalling network
###end article-title 105
###begin article-title 106
Identification of the scaramanga gene implicates Neuregulin3 in mammary gland specification
###end article-title 106
###begin article-title 107
Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5
###end article-title 107
###begin article-title 108
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality
###end article-title 108
###begin article-title 109
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
The breast proto-oncogene, HRGalpha regulates epithelial proliferation and lobuloalveolar development in the mouse mammary gland
###end article-title 109
###begin article-title 110
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
###end article-title 110
###begin article-title 111
ErbB2 is required for ductal morphogenesis of the mammary gland
###end article-title 111
###begin article-title 112
Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth
###end article-title 112
###begin article-title 113
Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development
###end article-title 113
###begin article-title 114
Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin
###end article-title 114
###begin article-title 115
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles
###end article-title 115
###begin article-title 116
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice
###end article-title 116
###begin article-title 117
###xml 51 66 <span type="species:ncbi:10090">transgenic mice</span>
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated cneu oncogene
###end article-title 117
###begin article-title 118
###xml 43 58 <span type="species:ncbi:10090">transgenic mice</span>
###xml 72 76 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
###end article-title 118
###begin article-title 119
###xml 49 64 <span type="species:ncbi:10090">transgenic mice</span>
Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development
###end article-title 119
###begin article-title 120
The stimulation of epidermal proliferation by a specific protein (EGF)
###end article-title 120
###begin article-title 121
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal
###end article-title 121
###begin article-title 122
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse
###end article-title 122
###begin article-title 123
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype
###end article-title 123
###begin article-title 124
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Strain-dependent epithelial defects in mice lacking the EGF receptor
###end article-title 124
###begin article-title 125
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development
###end article-title 125
###begin article-title 126
###xml 62 66 <span type="species:ncbi:10090">mice</span>
A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation
###end article-title 126
###begin article-title 127
###xml 28 33 <span type="species:ncbi:9606">human</span>
A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin
###end article-title 127
###begin article-title 128
Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands
###end article-title 128
###begin article-title 129
###xml 93 98 <span type="species:ncbi:9606">human</span>
Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes
###end article-title 129
###begin article-title 130
###xml 91 96 <span type="species:ncbi:9606">human</span>
Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes
###end article-title 130
###begin article-title 131
The role of heregulin-alpha as a motility factor and amphiregulin as a growth factor in wound healing
###end article-title 131
###begin article-title 132
Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds
###end article-title 132
###begin article-title 133
###xml 70 75 <span type="species:ncbi:9606">human</span>
ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells
###end article-title 133
###begin article-title 134
###xml 34 40 <span type="species:ncbi:9986">rabbit</span>
Wandering epithelial cells in the rabbit embryo milk line. A preliminary scanning electron microscope study
###end article-title 134
###begin article-title 135
On the developmental processes in mammary glands and other epidermal structures
###end article-title 135
###begin article-title 136
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
On the prenatal growth of the mammary gland rudiment in the mouse
###end article-title 136
###begin article-title 137
Epidermal stem cells of the skin
###end article-title 137
###begin article-title 138
The mammary bud as a skin appendage: unique and shared aspects of development
###end article-title 138
###begin article-title 139
Molecular mechanisms controlling dorsal dermis generation from the somitic dermomyotome
###end article-title 139
###begin article-title 140
Epidermal stem cells: an update
###end article-title 140
###begin article-title 141
Programming gene expression in developing epidermis
###end article-title 141
###begin article-title 142
###xml 60 65 <span type="species:ncbi:9606">human</span>
Expression of the c-erbB- 4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types
###end article-title 142
###begin article-title 143
Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes
###end article-title 143
###begin article-title 144
Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants
###end article-title 144
###begin article-title 145
A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester
###end article-title 145
###begin article-title 146
Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase
###end article-title 146
###begin article-title 147
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells
###end article-title 147
###begin article-title 148
The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells
###end article-title 148
###begin article-title 149
The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone
###end article-title 149
###begin article-title 150
ErbB-4: mechanism of action and biology
###end article-title 150
###begin article-title 151
gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase
###end article-title 151
###begin article-title 152
###xml 25 31 <span type="species:ncbi:10090">murine</span>
Keratin 2e: a marker for murine nipple epidermis
###end article-title 152
###begin article-title 153
K15 expression implies lateral differentiation within stratified epithelial basal cells
###end article-title 153
###begin article-title 154
Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge
###end article-title 154
###begin article-title 155
Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes
###end article-title 155
###begin article-title 156
Deregulated expression of c-Myc depletes epidermal stem cells
###end article-title 156
###begin article-title 157
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny
###end article-title 157
###begin article-title 158
Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes
###end article-title 158
###begin article-title 159
p63 identifies keratinocyte stem cells
###end article-title 159
###begin article-title 160
p63 is the molecular switch for initiation of an epithelial stratification program
###end article-title 160
###begin article-title 161
p63 Is essential for the proliferative potential of stem cells in stratified epithelia
###end article-title 161
###begin article-title 162
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Evidence for discrete cell kinetic subpopulations in mouse epidermis based on mathematical analysis
###end article-title 162
###begin article-title 163
Specificity within the EGF family/ErbB receptor family signaling network
###end article-title 163
###begin article-title 164
Ligand discrimination by ErbB receptors:differential signaling through differential phosphorylation site usage
###end article-title 164
###begin article-title 165
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4
###end article-title 165
###begin article-title 166
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
###end article-title 166
###begin article-title 167
ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases
###end article-title 167
###begin article-title 168
Requirement for neuregulin receptor erbB2 in neural and cardiac development
###end article-title 168
###begin article-title 169
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
###end article-title 169
###begin article-title 170
Multiple essential functions of neuregulin in development
###end article-title 170
###begin article-title 171
###xml 67 72 <span type="species:ncbi:9606">human</span>
Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation
###end article-title 171
###begin article-title 172
Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain
###end article-title 172
###begin article-title 173
Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain
###end article-title 173
###begin article-title 174
Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development
###end article-title 174
###begin article-title 175
erbB-1 and erbB-4 receptors act in concert to facilitate female sexual development and mature reproductive function
###end article-title 175
###begin article-title 176
###xml 82 87 <span type="species:ncbi:9606">human</span>
Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells
###end article-title 176
###begin article-title 177
ErbB receptors: new insights on mechanisms and biology
###end article-title 177
###begin article-title 178
Binding specificities and affinities of egf domains for ErbB receptors
###end article-title 178
###begin article-title 179
ErbB2 expression increases the spectrum and potency of ligand mediated signal transduction through ErbB4
###end article-title 179
###begin article-title 180
The ErbB signaling network: receptor heterodimerization in development and cancer
###end article-title 180
###begin article-title 181
The involvement of ErbB4 with schizophrenia: association and expression studies
###end article-title 181
###begin article-title 182
Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice variant expression in the brain in schizophrenia
###end article-title 182
###begin article-title 183
Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cellgrowth
###end article-title 183
###begin article-title 184
Identification of c-MYC as a target of the APC pathway
###end article-title 184
###begin article-title 185
The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway
###end article-title 185
###begin article-title 186
Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells
###end article-title 186
###begin article-title 187
Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin
###end article-title 187
###begin article-title 188
The canonical Wnt pathway in early mammalian embryogenesis and stem cell maintenance/differentiation
###end article-title 188
###begin article-title 189
###xml 15 21 <span type="species:ncbi:10090">murine</span>
Enrichment for murine keratinocyte stem cells based on cell surface phenotype
###end article-title 189
###begin article-title 190
###xml 33 38 <span type="species:ncbi:9606">human</span>
Stem cell patterning and fate in human epidermis
###end article-title 190
###begin article-title 191
###xml 33 39 <span type="species:ncbi:10090">murine</span>
Selection and extended growth of murine epidermal stem cells in culture
###end article-title 191
###begin article-title 192
###xml 78 83 <span type="species:ncbi:9606">human</span>
Signaling via beta1 integrins and mitogen activated protein kinase determines human epidermal stem cell fate in vitro
###end article-title 192
###begin article-title 193
Skin and hair follicle integrity is crucially dependent on beta 1 integrin expression on keratinocytes
###end article-title 193
###begin article-title 194
Conditional ablation of beta1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination
###end article-title 194
###begin article-title 195
Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions
###end article-title 195
###begin article-title 196
Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis
###end article-title 196
###begin article-title 197
Evidence that Myc activation depletes the epidermal stem cell compartment by modulating adhesive interactions with the local microenvironment
###end article-title 197
###begin article-title 198
Deconstructing myc
###end article-title 198
###begin article-title 199
Action of Myc in vivo - proliferation and apoptosis
###end article-title 199
###begin article-title 200
###xml 58 73 <span type="species:ncbi:10090">transgenic mice</span>
The c-myc proto-oncogene regulates cardiac development in transgenic mice
###end article-title 200
###begin article-title 201
c-Myc enhances protein synthesis and cell size during B lymphocyte development
###end article-title 201
###begin article-title 202
The Myc/Max/Mad network and the transcriptional control of cell behavior
###end article-title 202
###begin article-title 203
Out of Eden: stem cells and their niches
###end article-title 203
###begin article-title 204
Role of integrins in regulating epidermal adhesion, growth and differentiation
###end article-title 204
###begin article-title 205
Stem cells find their niche
###end article-title 205
###begin article-title 206
###xml 113 118 <span type="species:ncbi:10090">mouse</span>
Differential alteration of stem and other cell populations in ducts and lobules of TGFalpha and c-Myc transgenic mouse mammary epithelium
###end article-title 206
###begin article-title 207
Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplication and stem cell amplification
###end article-title 207
###begin article-title 208
###xml 36 41 <span type="species:ncbi:9606">human</span>
Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence
###end article-title 208
###begin article-title 209
Stem cell depletion through epidermal deletion of Rac1
###end article-title 209
###begin article-title 210
Designer skin: lineage commitment in postnatal epidermis
###end article-title 210
###begin article-title 211
Morphogenesis and renewal of hair follicles from adult multipotent stem cells
###end article-title 211
###begin article-title 212
p63 is a p53 homologue required for limb and epidermal morphogenesis
###end article-title 212
###begin article-title 213
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
###end article-title 213
###begin article-title 214
p63 regulates an adhesion programme and cell survival in epithelial cells
###end article-title 214
###begin article-title 215
Stratification and terminal differentiation of cultured epidermal cells
###end article-title 215
###begin article-title 216
Actin cable dynamics and Rho/Rock orchestrate a polarized cytoskeletal architecture in the early steps of assembling a stratified epithelium
###end article-title 216
###begin article-title 217
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Variation in the plane of cell cleavage during the process of stratification in the mouse epidermis
###end article-title 217
###begin article-title 218
Asymmetric cell divisions promote stratification and differentiation of mammalian skin
###end article-title 218
###begin article-title 219
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse embryonic submandibular gland epithelium loses its tissue integrity during early branching morphogenesis
###end article-title 219
###begin article-title 220
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Remodeling of desmosomal and hemidesmosomal adhesion systems during early morphogenesis of mouse pelage hair follicles
###end article-title 220
###begin article-title 221
Changes in adhesive properties of epithelial cells during early morphogenesis of the mammary gland
###end article-title 221
###begin article-title 222
Links between signal transduction, transcription and adhesion in epithelial bud development
###end article-title 222
###begin article-title 223
Supersaturated solution of fat stains in dilute isopropanol for demonstration of acute fatty degeneration not shown by Herxheimer technique
###end article-title 223
###begin article-title 224
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland
###end article-title 224

